Viatrin

Viatrin is a pharmaceutical product primarily manufactured by Genome Pharmaceuticals in Pakistan. It is used as an anti-epileptic medication, specifically for the treatment of complex partial seizures in individuals with epilepsy. The active ingredient in Viatrin is Vigabatrin, which helps control and reduce the frequency of seizures. The product is available in 500 mg tablet form, with packaging options of 10, 20, and 30 tablets. The pricing varies accordingly. Viatrin is also indicated for the treatment of infantile spasms in babies. The medication should be used under the supervision of a healthcare professional, and patients are advised to be aware of potential side effects, including visual field defects, and to consult with their doctor regarding any concerns. Viatrin is produced primarily in Pakistan, but it may also be manufactured in other locations. The brand is owned by Viatris Inc., a global healthcare company headquartered in the United States, which focuses on providing access to medicines across a broad range of therapeutic areas.